In HRSdx cells, the decrease in HLA-DR expression could favor the escape from immune system recognition and the increase in CD58, by improving the interactions with CD40L+CD2+ rosetting T cells, and could support tumor cell survival [26]. The gene discussed is CD2; the disease is neoplasm.